tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Gilead Sciences (GILD)
NASDAQ:GILD
US Market
GILD
Gilead Sciences
RESEARCH TOOLSreports

Gilead Sciences (GILD) Stock News & Sentiment

Compare
13,818 Followers
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
Premium
Market News
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
15h ago
GSK
GILD
Buy Rating on Gilead Driven by HIV Franchise Momentum and Upside from Yeztugo and Biktarvy
Premium
Ratings
Buy Rating on Gilead Driven by HIV Franchise Momentum and Upside from Yeztugo and Biktarvy
1d ago
GILD
Gilead Ends Obeldesivir Filovirus Prophylaxis Trial: What It Means for GILD Investors
Premium
Company Announcements
Gilead Ends Obeldesivir Filovirus Prophylaxis Trial: What It Means for GILD Investors
4d ago
GILD
3 Best ETFs to Invest In, According to AI Analyst, 03/10/2026
Premium
Market News
3 Best ETFs to Invest In, According to AI Analyst, 03/10/2026
14d ago
JNJ
MRK
The Week That Was, The Week Ahead: Macro and Markets, Mar. 8
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, Mar. 8
16d ago
AA
DG
Gilead Sciences: Advancing Long-Acting HIV Franchise Underscores Competitive Edge and Supports Buy Rating
Premium
Ratings
Gilead Sciences: Advancing Long-Acting HIV Franchise Underscores Competitive Edge and Supports Buy Rating
27d ago
GILD
Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target
Premium
Ratings
Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target
27d ago
GILD
More GILD News >

GILD News on the Web

Gilead Sciences to acquire Ouro Medicines, expanding autoimmune therapy portfolio
Proactive Investors
Bullish
U.S Stocks Futures Pullback as Middle East Jitters Trump Peace Hopes
GuruFocus News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Apogee Therapeutics (APGE) and Gilead Sciences (GILD)
TipRanks News
Bullish
Scotiabank Reaffirms Their Buy Rating on Gilead Sciences (GILD)
TipRanks News
Bullish
Galapagos in partnership discussions with Gilead after Ouro deal
TipRanks News
Bullish
Gilead Sciences (GILD) Acquires Ouro Medicines for $1.675 Billion
GuruFocus News
Bullish
Gilead Sciences To Acquire Ouro Medicines
rttnews
Bullish
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
GILD
Sector Average
Media Buzz
This Week17 articles
Weekly Average15.25 articles
News Sentiment
This Week92%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GILD’s Media Buzz Sentiment?
17 articles about GILD were published this week. In an average week, 15.25 articles are published.
    What is GILD’s weekly average amount of articles?
    In an average week, 15.25 articles about GILD are published.
      What is GILD’s News Sentiment?
      92% of articles about GILD were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        HYPRHyperfine
        OVIDOvid Therapeutics
        ALMSAlumis Inc.
        NWPHFNewron Pharmaceuticals SpA
        PBHPrestige Consumer Healthcare
        Showing the stocks with the most bullish news sentiment over the past week